: Management Discussion and Analysis For the years ended 31 December 2019 Summary of Performance Sales Revenue For the years ended 31 December 2018 and 2019, the Company recorded total sales revenue of THB

ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the operation and delivery of the Company's projects that cause the operation to be delayed than

recorded total sales revenue of THB 733.57 million and THB 384.43 million respectively. This equals to a sharp decline of 47.59% year on year. Domestic sales revenue dropped 46.25% from the same period of

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

2018, Sales revenue of the Company was recorded at THB 1,256.44 million and THB 983.36 million respectively or equivalent to a drop of 21.73% which is considered a consecutive decline from the last

, the Company recorded total sales revenue of THB 983.36 million and THB 557.33 million respectively. This equals to a sharp decline of 4 3.32% year on year. Domestic sales revenue dropped 43.28% from the

reducing production cost and also negotiating with customers to review and adjust selling price every quarter. 2.2. Distribution costs for 2018 was in the amount of 4.95 million baht, increased by 1.16

decreased from Q2–2019. This is because several projects in Q2–2020 were affected by the ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the

to adjust downward. Especially, sales through the industrial channel which has severely affected, as such the industrial market has high degrees of competition. 2. The Marketing Business Group recorded

charge of Baht 13 million to adjust the retirement benefits in accordance with the latest changes in Labor Protection Act. A plot of land, non-performing assets had been sold in December with a net gain of